Kent Imaging Responds to a Complaint Filed with the ITC Concerning SnapshotGLO® and Reaffirms Commitment to Clinical Innovation

Kent Imaging today issued a statement regarding the complaint filed by MolecuLight Corp. and MolecuLight Inc. in the U.S. International Trade Commission (ITC). The complaint alleges that Kent Imaging’s SnapshotGLO®, which recently received FDA 510(k) clearance, infringes a patent to which MolecuLight purports to have a license. Kent Imaging denies all allegations of patent infringement […]

Mu Digital Launches “Infinite Ways to Earn” Campaign to Bootstrap Liquidity for $20T Asia Credit Market Onchain

Mu Digital, a Web3 platform bringing Asia’s credit markets onchain, announced the launch of its multi-month incentive campaign, “Infinite Ways to Earn”. The campaign offers a range of incentives, including Mu Digital points and rewards provided by integration partners. The event will begin in January 2026 and will run through 1H2026. The initiative is designed

FDA Grants Regenerative Medicine Advanced Therapy (RMAT) Designation to iRegene’s NouvNeu001, Making It the World’s First iPSC Therapy with Both FTD and RMAT Recognitions

Designation underscores potential of chemically induced, off-the-shelf cell therapy to address high unmet need in Parkinson's disease, following compelling Phase I clinical data iRegene Therapeutics Co., Ltd. (“iRegene” or the “Company”), a biotechnology company pioneering chemically induced allogeneic cell therapy, today announced that its lead product, NouvNeu001, has been granted Regenerative Medicine Advanced Therapy (RMAT)

Frontieras North America Closes on 183-Acre Site in West Virginia for $850M FASForm(TM) Facility

Hydrocarbon Investment Brings Zero Waste, Coal Reformation, Thousands of Jobs, and Long-Term Economic Growth to West Virginia Frontieras North America has officially closed on 183 acres of riverfront property in Mason County, West Virginia, where it will build its flagship $850 million FASForm(TM) facility, marking a major step forward in the company’s plan to commercialize

Probo Medical Partners with Maclean Group LLC to Offer Ultrasound Probe and Endoscopy Repair on Federal Supply Schedule – FSS Contract Number: 36F79723D0201

Probo Medical, a global leader in medical imaging equipment and repair services, is proud to announce that, in partnership with Maclean Group LLC, a Service-Disabled Veteran-Owned Small Business (SDVOSB), its ultrasound probe and endoscope repair services are now available on the Federal Supply Schedule (FSS). This inclusion under FSS Contract #36F79723D0201 enables federal agencies –

MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO

(TSX:LABS),(OTC US:MEDIF),(Other OTC:MEDIF),(Boerse Frankfurt – Freiverkehr:MLZ), TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that David Pidduck will be stepping down from his role as the Company's Chief Executive Officer, effective January 23rd, 2026.

Really Cheap Floors Releases New Study on The Return of Consumer Demand for Real American Hardwood as Homeowners Prioritize Value Over Vinyl

Murphy, NC, Jan. 19, 2026 (GLOBE NEWSWIRE) — Really Cheap Floors, a national direct-to-consumer flooring liquidator, is happy to announce the release of its new study on the return of consumer demand for real American hardwood floors as recent trends show homeowners are now prioritizing value over vinyl. After a decade of market saturation by

REV Provides Corporate Update

(TSX-V – NEX Board:REVX),(OTC US:REVFF),(OtherOTC:REVFF),(CNSX:MAXX.CN),(PinkSheets:MAXXF), VANCOUVER, British Columbia, Jan. 19, 2026 (GLOBE NEWSWIRE) — REV Exploration Corp. (“REV“ or the “Company“) (TSXV: REVX; OTCID: REVFF) is pleased to provide the following corporate update: Highlights REV has completed its largest raise ever, closing concurrent private placements totaling $5.8 million (no warrants issued) with a lead order

Kaleo Strengthens Leadership Team to Advance Drug Delivery and Autoinjector Innovation

Richmond, VA, Jan. 19, 2026 (GLOBE NEWSWIRE) — Kaleo, a global leader in drug-delivery device technology and auto-injectors, today announced the appointment of Ram Halthore as Vice President, Development. He joins Carrie Siragusa, CPA, who was welcomed last year as Vice President, Marketing and Public Relations, reflecting the Company's continued investment in leadership to support

Scroll to Top